TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2024 Financial Results
TOMI Environmental Solutions (NASDAQ: TOMZ) reported its Q4 and full-year 2024 financial results, showing mixed performance. Annual revenue increased by 5% to $7.74 million, with international revenue growing 33%. However, the company faced significant challenges with GAAP net loss widening to $(4.48 million) or $(0.22) per share in 2024, compared to $(3.40 million) or $(0.17) per share in 2023.
Q4 2024 showed particular weakness with net sales declining to $1.07 million from $1.53 million in Q4 2023, and gross margin turning negative at -49.5%. However, preliminary Q1 2025 results indicate a strong rebound with revenue up 42% to $1.58 million and solution sales growing approximately 200% quarter-over-quarter. The company's sales backlog increased 40% to $1.23 million by March 2025.
TOMI Environmental Solutions (NASDAQ: TOMZ) ha comunicato i risultati finanziari del quarto trimestre e dell’intero anno 2024, evidenziando una performance mista. Il fatturato annuo è aumentato del 5% raggiungendo 7,74 milioni di dollari, con una crescita del 33% dei ricavi internazionali. Tuttavia, l’azienda ha affrontato importanti difficoltà, con una perdita netta GAAP che si è ampliata a $(4,48) milioni o $(0,22) per azione nel 2024, rispetto a $(3,40) milioni o $(0,17) per azione nel 2023.
Il quarto trimestre 2024 ha mostrato particolare debolezza, con vendite nette in calo a 1,07 milioni di dollari rispetto a 1,53 milioni nel Q4 2023, e un margine lordo negativo del -49,5%. Tuttavia, i risultati preliminari del primo trimestre 2025 indicano una forte ripresa, con ricavi in crescita del 42% a 1,58 milioni di dollari e vendite di soluzioni aumentate di circa il 200% trimestre su trimestre. Il portafoglio ordini dell’azienda è cresciuto del 40%, raggiungendo 1,23 milioni di dollari a marzo 2025.
TOMI Environmental Solutions (NASDAQ: TOMZ) informó sus resultados financieros del cuarto trimestre y del año completo 2024, mostrando un desempeño mixto. Los ingresos anuales aumentaron un 5% hasta 7,74 millones de dólares, con un crecimiento del 33% en los ingresos internacionales. Sin embargo, la compañía enfrentó desafíos significativos, con una pérdida neta GAAP que se amplió a $(4,48) millones o $(0,22) por acción en 2024, en comparación con $(3,40) millones o $(0,17) por acción en 2023.
El cuarto trimestre de 2024 mostró debilidad particular, con ventas netas que disminuyeron a 1,07 millones de dólares desde 1,53 millones en el Q4 de 2023, y un margen bruto negativo del -49,5%. No obstante, los resultados preliminares del primer trimestre de 2025 indican una fuerte recuperación, con ingresos que aumentaron un 42% hasta 1,58 millones de dólares y ventas de soluciones que crecieron aproximadamente un 200% trimestre a trimestre. La cartera de pedidos de la empresa aumentó un 40%, alcanzando 1,23 millones de dólares en marzo de 2025.
TOMI Environmental Solutions (NASDAQ: TOMZ)은 2024년 4분기 및 연간 재무 실적을 발표하며 혼재된 성과를 보였습니다. 연간 매출은 5% 증가한 774만 달러를 기록했으며, 해외 매출은 33% 성장했습니다. 그러나 회사는 GAAP 순손실이 2023년 $(340만) 또는 주당 $(0.17)에서 2024년 $(448만) 또는 주당 $(0.22)로 확대되는 등 큰 어려움에 직면했습니다.
2024년 4분기는 특히 부진하여 순매출이 2023년 4분기 153만 달러에서 107만 달러로 감소했고, 총이익률은 -49.5%로 마이너스를 기록했습니다. 그러나 2025년 1분기 예비 실적은 매출이 42% 증가한 158만 달러를 기록하며 강한 반등을 보였고, 솔루션 매출은 전분기 대비 약 200% 증가했습니다. 회사의 판매 잔고는 2025년 3월 기준 40% 증가한 123만 달러에 달했습니다.
TOMI Environmental Solutions (NASDAQ : TOMZ) a publié ses résultats financiers du quatrième trimestre et de l’année complète 2024, montrant une performance mitigée. Le chiffre d’affaires annuel a augmenté de 5 % pour atteindre 7,74 millions de dollars, avec une croissance de 33 % des revenus internationaux. Cependant, l’entreprise a rencontré des difficultés importantes, la perte nette selon les normes GAAP s’étant creusée à (4,48 millions de dollars) ou (0,22 $) par action en 2024, contre (3,40 millions de dollars) ou (0,17 $) par action en 2023.
Le quatrième trimestre 2024 a été particulièrement faible, avec des ventes nettes en baisse à 1,07 million de dollars contre 1,53 million au T4 2023, et une marge brute devenue négative à -49,5 %. Toutefois, les résultats préliminaires du premier trimestre 2025 indiquent un fort rebond, avec un chiffre d’affaires en hausse de 42 % à 1,58 million de dollars et des ventes de solutions en croissance d’environ 200 % d’un trimestre à l’autre. Le carnet de commandes de l’entreprise a augmenté de 40 %, atteignant 1,23 million de dollars en mars 2025.
TOMI Environmental Solutions (NASDAQ: TOMZ) berichtete über seine Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 und zeigte eine gemischte Leistung. Der Jahresumsatz stieg um 5 % auf 7,74 Millionen US-Dollar, wobei der internationale Umsatz um 33 % wuchs. Allerdings hatte das Unternehmen erhebliche Herausforderungen zu bewältigen, da der GAAP-Nettogewinnverlust auf $(4,48) Millionen oder $(0,22) pro Aktie im Jahr 2024 anstieg, verglichen mit $(3,40) Millionen oder $(0,17) pro Aktie im Jahr 2023.
Das vierte Quartal 2024 zeigte besondere Schwäche mit einem Rückgang der Nettoumsätze auf 1,07 Millionen US-Dollar von 1,53 Millionen im vierten Quartal 2023, und die Bruttomarge wurde mit -49,5 % negativ. Vorläufige Ergebnisse für das erste Quartal 2025 deuten jedoch auf eine starke Erholung hin, mit einem Umsatzanstieg von 42 % auf 1,58 Millionen US-Dollar und einem etwa 200%igen Wachstum der Lösungsverkäufe im Quartalsvergleich. Der Auftragsbestand des Unternehmens stieg bis März 2025 um 40 % auf 1,23 Millionen US-Dollar.
- 42% revenue growth in preliminary Q1 2025 results
- 33% growth in international revenue for 2024
- 200% quarter-over-quarter growth in solution sales for Q1 2025
- 40% increase in sales backlog to $1.232 million by March 2025
- 5% annual revenue growth in 2024
- GAAP net loss increased to $(4.477 million) in 2024 from $(3.403 million) in 2023
- Q4 2024 gross margin turned negative at -49.5% compared to 54.9% in Q4 2023
- Q4 2024 sales declined 30% year-over-year to $1.069 million
- Operating loss widened to $(4.105 million) in 2024 from $(3.349 million) in 2023
Insights
TOMI's financial results reveal a complex picture with contradictory indicators that require careful analysis. While annual revenue grew modestly at
The divergence between GAAP and non-GAAP metrics is striking. While GAAP operating losses worsened from
Liquidity appears concerning with cash declining from
The preliminary Q1 2025 results showing a
TOMI's strategic positioning appears to be improving despite financial difficulties. The company's international expansion with
The transition of Betatek from manufacturing representative to official distributor in Canada is particularly significant, as it indicates sufficient market demand to justify a more committed relationship. This partner elevation strategy could be replicated in other territories as volumes increase.
The company's diversification across education (Bonneville School District), pharmaceuticals (UK facility), and other sectors demonstrates versatility of their disinfection technology. However, the Q4 revenue decline of
The solution sales growth of
With
FREDERICK, Md., April 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its fourth quarter and year end 2024 financial results.
TOMI Chief Executive Officer, Dr. Halden Shane, stated, “For the year ended December 31, 2024, we increased our year-over-year annual revenue by
“During the fourth quarter we absorbed significant non-cash charges to certain reserve accounts which contributed to the GAAP net loss for the quarter and full year. Excluding these non-cash adjustments, our financials improved when compared to the prior year, and we expect continued improvement in 2025 as we are off to a great start with preliminary Q1 revenues up
The non-GAAP financial measures in the schedule below and under the sections “Financial Results for the Year/Three Months Ended December 31, 2024” below exclude the effect of the allowance for sales returns, inventory reserve, equity compensation expense, and credit loss expense in each of the periods presented. A detailed reconciliation of GAAP and non-GAAP financial measures is included at the end of this press release.
| GAAP FINANCIAL COMPARISON | ||||||||||||||||
| (UNAUDITED) | ||||||||||||||||
| For The Three Months Ended | For The Years Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Sales, net | $ | 1,069,000 | $ | 1,528,000 | $ | 7,739,000 | $ | 7,355,000 | ||||||||
| Gross Margin | ( | |||||||||||||||
| Operating Loss | $ | (3,149,000) | $ | (1,171,000) | $ | (4,105,000) | $ | (3,349,000) | ||||||||
| Net (Loss) | $ | (3,256,000) | $ | (1,226,000) | $ | (4,477,000) | $ | (3,403,000) | ||||||||
| Net (Loss) per Share | $ | (0.16) | $ | (0.06) | $ | (0.22) | $ | (0.17) | ||||||||
| NON-GAAP FINANCIAL COMPARISON | ||||||||||||||||
| (UNAUDITED) | ||||||||||||||||
| For The Three Months Ended | For The Years Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Sales, gross | $ | 1,296,000 | $ | 1,656,000 | $ | 7,966,000 | $ | 7,483,000 | ||||||||
| Non-GAAP Gross Margin | ||||||||||||||||
| Non-GAAP Operating Loss | $ | (874,000) | $ | (747,000) | $ | (1,678,000) | $ | (2,785,000) | ||||||||
| Non-GAAP Net (Loss) | $ | (981,000) | $ | (802,000) | $ | (2,050,000) | $ | (2,838,000) | ||||||||
| Non-GAAP Net (Loss) per Share | $ | (0.05) | $ | (0.04) | $ | (0.10) | $ | (0.14) | ||||||||
Financial Results for the year ended December 31, 2024, compared to December 31, 2023
- Total sales, net was
$7,739,000 compared to$7,355,000 for the years ended December 31, 2024 and 2023, respectively, representing5% year-over-year growth. Non-GAAP gross sales excluding sales returns was$7,966,000 compared to$7,483,000 , which represents a6% increase compared to last year. - GAAP gross margin was
46% compared to58% in the prior year. Non-GAAP gross margin was60% compared to59% in the prior year. - GAAP operating loss was
$(4,105,000) compared to$(3,349,000) in the prior year. Non-GAAP operating loss was$(1,678,000) compared to$(2,785,000) in the prior year. - GAAP net loss was
$(4,477,000) or$(0.22) per basic and diluted share, compared to$(3,403,000) or$(0.17) per basic and diluted share. Non-GAAP net loss was$(2,050,000) or$(0.10) per basic and diluted share, compared to$(2,838,000) or$(0.14) per basic and diluted share in the prior year.
Financial Results for the three months ended December 31, 2024, compared to December 31, 2023
- Total sales, net was
$1,069,000 compared to$1,528,000 for the three months ended December 31, 2024 and 2023, respectively. Non-GAAP gross sales was$1,296,000 compared to$1,656,000 in the same period last year. - GAAP gross margin was (
50% ) compared to55% in the prior year. Non-GAAP gross margin was54% compared to58% in the same period last year. - GAAP operating loss was
$(3,149,000) , compared to$(1,171,000) in the prior year. Non-GAAP operating loss was$(874,000) compared to$(747,000) in the same period last year. - GAAP net loss was
$(3,256,000) or$(0.16) per basic and diluted share, compared to$(1,226,000) or$(0.06) per basic and diluted share in the same period last year. Non-GAAP net loss was$(981,000) or$(0.05) per basic and diluted share, compared to$(802,000) or$(0.04) per basic and diluted share in the same period last year.
Recent Business Highlights:
- SteraMist product-based revenues for the years ended December 31, 2024 and 2023, were
$6,035,000 and$5,781,000 , representing an increase of$254,000 when compared to the same prior year period. The higher revenue was attributable to increased demand for our mobile and SIS units. - Our service-based revenue for the years ended December 31, 2024 and 2023, was
$1,704,000 and$1,574,000 , respectively, representing a year over year increase of$130,000. T he higher revenue was attributable to increased demand for our iHP services. - Sales backlog at December 31, 2024 was
$877,000. Sales backlog has increased to$1,232,000 as of March 31, 2025. - Our international revenue for the year ended December 31, 2024 grew by
33% , driven by new customers in Canada, South Africa, and India, compared to the same period in 2023. - Many existing relationships expanded and established new key contacts. Formally, we contracted with six different partners across various regions, including Malaysia, India, Canada, Korea, and the United Kingdom. These collaborations span industries such as pharmaceuticals, vivarium, emergency services, and general disinfection and cleaning. We are committed to nurturing these partnerships alongside our other 30 partners to further develop and strengthen the SteraMist brand in the global market.
- Bonneville Joint School District No. 93, located in Bonneville County, Idaho, has integrated SteraMist technology into its cleaning protocols. This adoption underscores the district’s commitment to prioritizing the health and safety of its students and staff through advanced disinfection measures and demonstrates the versatility of our SteraMist technology and products to serve educational institutions
- Expanded our partnership with Betatek, Inc. ("Betatek"), transitioning the long-term Canadian partner from an independent manufacturing representative to an official SteraMist distributor. This strategic move comes in response to the increasing demand for SteraMist in the Canadian market.
- Installation of the Custom Engineered Solution (CES) at a renowned pharmaceutical facility in the United Kingdom.
Preliminary Q1 2025 Results:
We head into 2025 with the strongest pipeline we have ever seen in our business. With our high gross margins and continued growth of our high margin solutions sales, as well as a reduced expense structure, we are well positioned to drive improving profitability as we move through 2025.
- Preliminary revenues of approximately
$1,577,000 compared to$1,114,000 for the three months ended March 31, 2024, an increase of42% . - Sales backlog of approximately
$1,232,000 , a40% increase from December 31, 2024. - Preliminary quarter over quarter growth in solution sales of approximately
200% .
The above unaudited financial results for Q1 2025 are preliminary and subject to the completion of accounting and quarterly review procedures and are therefore subject to adjustment.
Conference Call Information
TOMI will hold a conference call to discuss Fourth Quarter and Full Year 2024 results at 4:30 p.m. ET today, April 14, 2025.
To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled start time and provide participant access code 818389, or request the "TOMI Environmental Solutions fourth quarter earnings call." International callers please dial (973) 528-0011. To access the live webcast or view the press release, please visit the Investor Relations section of the TOMI website or register at the following link: https://www.webcaster4.com/Webcast/Page/2262/52313.
A replay of the teleconference will be available until Monday, April 28, 2025, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use replay access code: 52313. A replay of the webcast will be available for at least 90 days on the company’s website, starting approximately one hour after the completion of the call.
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas. TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.
Forward-Looking Statements
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, preliminary financial results for Q1 2025, our strategies to grow revenue and expand business development, financial performance and operating results for 2025; our ability to generate lead and referral for sales, and our ability to improve financial performance. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
Use of Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a basis consistent with U.S. GAAP, we disclose certain non-GAAP financial measures for our historical performance, including non-GAAP gross sales, non-GAAP gross margin, operating expenses, operating income (loss), net income (loss), and earnings per share (“EPS”). These supplemental measures exclude, among other items, the allowance for sales returns, equity compensation expenses, inventory reserves and credit loss expense. We believe that these non-GAAP financial measures provide useful information to both management and investors by excluding certain items and expenses that are not indicative of our core operating results or do not reflect our normal business operations. In addition, our management uses non-GAAP measures to compare our performance relative to forecasts and to benchmark our performance externally against competitors. Our use of non-GAAP financial measures has certain limitations in that such non-GAAP financial measures may not be directly comparable to those reported by other companies. For example, the terms used in this press release, such as non-GAAP net income (loss) or non-GAAP operating expenses, do not have a standardized meaning. Other companies may use the same or similarly named measures, but exclude different items, which may not provide investors with a comparable view of our performance in relation to other companies. We seek to compensate for the limitation of our non-GAAP presentation by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable U.S. GAAP measures both in the text in this press release and in the tables attached hereto. Investors are encouraged to review the related U.S. GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable U.S. GAAP financial measures.
The following represents our consolidated balance sheets and statement of operations from our recently filed Form 10-K:
| TOMI ENVIRONMENTAL SOLUTIONS, INC. | |||||||
| CONSOLIDATED BALANCE SHEETS | |||||||
| ASSETS | |||||||
| Current Assets: | December 31, 2024 | December 31, 2023 | |||||
| Cash and Cash Equivalents | $ | 664,879 | $ | 2,339,059 | |||
| Accounts Receivable - net | 1,881,138 | 2,429,929 | |||||
| Other Receivables | - | 164,150 | |||||
| Inventories, net | 3,578,202 | 4,627,103 | |||||
| Vendor Deposits | 35,895 | 29,335 | |||||
| Prepaid Expenses | 332,999 | 371,298 | |||||
| Total Current Assets | 6,493,113 | 9,960,874 | |||||
| Property and Equipment – net | 875,449 | 1,048,642 | |||||
| Other Assets: | |||||||
| Intangible Assets – net | 1,250,574 | 1,123,246 | |||||
| Operating Lease - Right of Use Asset | 399,254 | 467,935 | |||||
| Long Term Accounts Receivable - net | - | 206,240 | |||||
| Other Assets | 675,348 | 550,677 | |||||
| Total Other Assets | 2,325,176 | 2,348,098 | |||||
| Total Assets | $ | 9,693,738 | $ | 13,357,614 | |||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
| Current Liabilities: | |||||||
| Accounts Payable | $ | 1,924,379 | $ | 1,267,029 | |||
| Accrued Expenses and Other Current Liabilities | 455,675 | 675,491 | |||||
| Deferred Revenue | 211,724 | - | |||||
| Current Portion of Long-Term Operating Lease | 129,132 | 115,658 | |||||
| Total Current Liabilities | 2,720,910 | 2,058,178 | |||||
| Long-Term Liabilities: | |||||||
| Long-Term Operating Lease, Net of Current Portion | 513,395 | 642,527 | |||||
| Convertible Notes Payable, net of unamortized debt discount of | 2,360,494 | 2,298,015 | |||||
| Total Long-Term Liabilities | 2,873,889 | 2,940,542 | |||||
| Total Liabilities | 5,594,799 | 4,998,720 | |||||
| Commitments and Contingencies | - | - | |||||
| Shareholders’ Equity: | |||||||
| Cumulative Convertible Series A Preferred Stock; par value | 638 | 638 | |||||
| Cumulative Convertible Series B Preferred Stock; | - | - | |||||
| Common stock; par value | 200,152 | 199,240 | |||||
| Additional Paid-In Capital | 58,201,140 | 57,985,245 | |||||
| Accumulated Deficit | (54,302,991) | (49,826,229) | |||||
| Total Shareholders’ Equity | 4,098,939 | 8,358,894 | |||||
| Total Liabilities and Shareholders’ Equity | $ | 9,693,738 | $ | 13,357,614 | |||
| TOMI ENVIRONMENTAL SOLUTIONS, INC. | ||||||||||||||||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||||
| For The Three Months Ended | For The Year Ended | |||||||||||||||||
| December 31, | December 31, | |||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||||
| Sales, net | $ | 1,069,112 | $ | 1,527,674 | $ | 7,738,842 | $ | 7,354,564 | ||||||||||
| Cost of Sales | 1,598,345 | 688,587 | 4,181,764 | 3,065,028 | ||||||||||||||
| Gross Profit | (529,233) | 839,087 | 3,557,078 | 4,289,536 | ||||||||||||||
| Operating Expenses: | ||||||||||||||||||
| Professional Fees | 210,098 | 119,210 | 597,365 | 575,728 | ||||||||||||||
| Depreciation and Amortization | 72,152 | 93,412 | 296,536 | 366,677 | ||||||||||||||
| Selling Expenses | 246,475 | 190,713 | 1,128,402 | 1,351,465 | ||||||||||||||
| Research and Development | 104,760 | 271,211 | 290,683 | 491,798 | ||||||||||||||
| Consulting Fees | 44,711 | 93,826 | 225,779 | 282,548 | ||||||||||||||
| General and Administrative | 1,941,769 | 1,241,871 | 5,123,073 | 4,570,597 | ||||||||||||||
| Total Operating Expenses | 2,619,965 | 2,010,243 | 7,661,838 | 7,638,813 | ||||||||||||||
| Income (loss) from Operations | (3,149,198) | (1,171,156) | (4,104,760) | (3,349,277) | ||||||||||||||
| Other Income (Expense): | ||||||||||||||||||
| Interest Income | 2,258 | 10,726 | 17,489 | 11,990 | ||||||||||||||
| Interest Expense | (108,792) | (65,305) | (389,491) | (65,305) | ||||||||||||||
| Total Other Income (Expense) | (106,534) | (54,579) | (372,002) | (53,315) | ||||||||||||||
| Income (loss) before income taxes | (3,255,732) | (1,225,735) | (4,476,762) | (3,402,592) | ||||||||||||||
| Provision for Income Taxes | - | - | - | - | ||||||||||||||
| Net Income (loss) | $ | (3,255,732) | $ | (1,225,735) | $ | (4,476,762) | $ | (3,402,592) | ||||||||||
| Net income (loss) Per Common Share | ||||||||||||||||||
| Basic | $ | (0.16) | $ | (0.06) | $ | (0.22) | $ | (0.17) | ||||||||||
| Diluted | $ | (0.16) | $ | (0.06) | $ | (0.22) | $ | (0.17) | ||||||||||
| Basic Weighted Average Common Shares Outstanding | 20,015,205 | 19,883,955 | 19,992,592 | 19,834,476 | ||||||||||||||
| Diluted Weighted Average Common Shares Outstanding | 20,015,205 | 19,883,955 | 19,992,592 | 19,834,476 | ||||||||||||||
| TOMI ENVIRONMENTAL SOLUTIONS, INC. | |||||||||||||||||
| RECONCILIATION OF CONSOLIDATED GAAP FINANCIALS TO NON-GAAP FINANCIALS | |||||||||||||||||
| (UNAUDITED) | |||||||||||||||||
| For The Three Months Ended | For The Years Ended | ||||||||||||||||
| December 31, | December 31, | ||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||
| GAAP Sales, net | $ | 1,069,112 | $ | 1,527,674 | $ | 7,738,842 | $ | 7,354,564 | |||||||||
| Allowance for Sales Returns | 227,000 | 128,390 | 227,000 | 128,390 | |||||||||||||
| NON-GAAP Sales, gross | $ | 1,296,112 | $ | 1,656,064 | $ | 7,965,842 | $ | 7,482,954 | |||||||||
| GAAP gross profit | $ | (529,233) | $ | 839,087 | $ | 3,557,078 | $ | 4,289,536 | |||||||||
| Allowance for Sales Returns | 227,000 | 128,390 | 227,000 | 128,390 | |||||||||||||
| Inventory Reserve | 1,005,000 | - | 1,005,000 | - | |||||||||||||
| Non-GAAP gross profit | $ | 702,767 | $ | 967,477 | $ | 4,789,078 | $ | 4,417,926 | |||||||||
| Non-GAAP gross margin as a % of revenue | |||||||||||||||||
| GAAP operating expenses | $ | 2,619,965 | $ | 2,010,243 | $ | 7,661,838 | $ | 7,638,813 | |||||||||
| Equity Compensation Expense | - | (4,453) | (144,307) | (163,286) | |||||||||||||
| Credit Loss Expense | (1,042,741) | (291,367) | (1,050,543) | (272,517) | |||||||||||||
| Non-GAAP operating expenses | $ | 1,577,224 | $ | 1,714,423 | $ | 6,466,988 | $ | 7,203,010 | |||||||||
| GAAP operating (loss) | $ | (3,149,198) | $ | (1,171,156) | $ | (4,104,760) | $ | (3,349,277) | |||||||||
| Allowance for Sales Returns | 227,000 | 128,390 | 227,000 | 128,390 | |||||||||||||
| Inventory Reserve | 1,005,000 | - | 1,005,000 | - | |||||||||||||
| Equity Compensation Expense | - | 4,453 | 144,307 | 163,286 | |||||||||||||
| Credit Loss Expense | 1,042,741 | 291,367 | 1,050,543 | 272,517 | |||||||||||||
| Non-GAAP operating (loss) | $ | (874,457) | $ | (746,946) | $ | (1,677,910) | $ | (2,785,084) | |||||||||
| GAAP net (loss) | $ | (3,255,732) | $ | (1,225,735) | $ | (4,476,762) | $ | (3,402,592) | |||||||||
| Allowance for Sales Returns | 227,000 | 128,390 | 227,000 | 128,390 | |||||||||||||
| Inventory Reserve | 1,005,000 | - | 1,005,000 | - | |||||||||||||
| Equity Compensation Expense | - | 4,453 | 144,307 | 163,286 | |||||||||||||
| Credit Loss Expense | 1,042,741 | 291,367 | 1,050,543 | 272,517 | |||||||||||||
| Non-GAAP net (loss) | $ | (980,991) | $ | (801,525) | $ | (2,049,912) | $ | (2,838,399) | |||||||||
| GAAP diluted net (loss) per share | $ | (0.16) | $ | (0.06) | $ | (0.22) | $ | (0.17) | |||||||||
| Allowance for Sales Returns | 0.01 | 0.01 | 0.01 | 0.01 | |||||||||||||
| Inventory Reserve | 0.05 | - | 0.05 | - | |||||||||||||
| Equity Compensation Expense | - | 0.00 | 0.01 | 0.01 | |||||||||||||
| Credit Loss Expense | 0.05 | 0.01 | 0.05 | 0.01 | |||||||||||||
| Non-GAAP diluted net (loss) per share | $ | (0.05) | $ | (0.04) | $ | (0.10) | $ | (0.14) | |||||||||
| Basic and Diluted Weighted Average Common Shares Outstanding | 20,015,205 | 19,883,955 | 19,992,592 | 19,834,476 | |||||||||||||
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
FAQ
What was TOMI Environmental Solutions (TOMZ) revenue growth in 2024?
How did TOMZ perform in Q4 2024 compared to Q4 2023?
What are TOMZ's preliminary Q1 2025 results?
How much did TOMZ's international revenue grow in 2024?
